Literature DB >> 26035050

Impact of APOBEC Mutations on CD8+ T Cell Recognition of HIV Epitopes Varies Depending on the Restricting HLA.

Krista D Squires1, Mahdis Monajemi, Claire F Woodworth, Michael D Grant, Mani Larijani.   

Abstract

We previously showed that APOBEC-mediated mutations in HIV CD8 T-cell epitopes generally reduce recognition by CD8 T cells. Here, we examined this effect in the context of histocompatibility-linked leukocyte antigen (HLA) alleles differentially associated with disease progression rates. For HLA-B57-restricted epitopes, APOBEC mutations generally diminished CD8 T cell recognition. Conversely, recognition of HLA-B35-restricted epitopes was consistently enhanced. For epitopes that can be presented by either HLA-A2 or A3, the same APOBEC mutation had differential effects on CD8 T cell recognition, depending on the individual's HLA genotype. The pattern of HLA dependence provides additional evidence that APOBEC action is channeled toward cytotoxic CD8 T-cell escape.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26035050     DOI: 10.1097/QAI.0000000000000689

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  12 in total

1.  RNA-Mediated Dimerization of the Human Deoxycytidine Deaminase APOBEC3H Influences Enzyme Activity and Interaction with Nucleic Acids.

Authors:  Yuqing Feng; Lai Wong; Michael Morse; Ioulia Rouzina; Mark C Williams; Linda Chelico
Journal:  J Mol Biol       Date:  2018-11-09       Impact factor: 5.469

2.  Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2.

Authors:  Morgan E Meissner; Nora A Willkomm; Jamie Lucas; William G Arndt; Sarah F Aitken; Emily J Julik; Sunanda Baliga; Louis M Mansky
Journal:  J Mol Biol       Date:  2021-11-10       Impact factor: 5.469

3.  Molecular Biology and Diversification of Human Retroviruses.

Authors:  Morgan E Meissner; Nathaniel Talledge; Louis M Mansky
Journal:  Front Virol       Date:  2022-06-02

Review 4.  Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.

Authors:  S Venkatesan; R Rosenthal; N Kanu; N McGranahan; J Bartek; S A Quezada; J Hare; R S Harris; C Swanton
Journal:  Ann Oncol       Date:  2018-03-01       Impact factor: 32.976

5.  Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2.

Authors:  Kristina Hopfensperger; Jonathan Richard; Christina M Stürzel; Frederic Bibollet-Ruche; Richard Apps; Marie Leoz; Jean-Christophe Plantier; Beatrice H Hahn; Andrés Finzi; Frank Kirchhoff; Daniel Sauter
Journal:  mBio       Date:  2020-07-14       Impact factor: 7.867

Review 6.  Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1.

Authors:  Marta Colomer-Lluch; Alba Ruiz; Arnaud Moris; Julia G Prado
Journal:  Front Immunol       Date:  2018-12-06       Impact factor: 7.561

7.  Role of co-expressed APOBEC3F and APOBEC3G in inducing HIV-1 drug resistance.

Authors:  Nazanin Mohammadzadeh; Robin P Love; Richard Gibson; Eric J Arts; Art F Y Poon; Linda Chelico
Journal:  Heliyon       Date:  2019-04-16

Review 8.  Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.

Authors:  Michael Grant; Mani Larijani
Journal:  AIDS Res Ther       Date:  2017-09-12       Impact factor: 2.250

9.  HLA-C Alleles and Cytomegalovirus Retinitis in Brazilian Patients with AIDS.

Authors:  Tânia Gisela Biberg-Salum; Maria de Lourdes Veronese Rodrigues; Ana Paula Morais Fernandes; Neifi Hassan Salum Deghaide; Jayter Silva de Paula; Erick C Castelli; Celso Teixeira Mendes-Junior; Eduardo Antonio Donadi
Journal:  J Ophthalmol       Date:  2018-09-02       Impact factor: 1.909

10.  APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome.

Authors:  Faezeh Borzooee; Krista D Joris; Michael D Grant; Mani Larijani
Journal:  Front Immunol       Date:  2019-01-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.